CIK 0001133416 · Non-accelerated filer<br>Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 043562325
- Phone
- 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise · Stock Option (right to buy) | −30,000 | 190,000 | ||
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise · Stock Option (right to buy) | −40,000 | 150,000 | ||
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise · Stock Option (right to buy) | −70,000 | 80,000 | ||
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise · Stock Option (right to buy) | −40,000 | 40,000 | ||
| 2025-06-06 | CZIRR JAMES C 10% owner | Option exercise · Stock Option (right to buy) | −40,000 | 0 | ||
| 2025-03-31 | CZIRR JAMES C 10% owner | Other acquisition | +1,000 | $6.00 | $6K | 722,416 |
| 2025-03-03 | LEWIS JOEL President and CEO | Grant or award | −56,420 | $1.57 | $89K | 832,592 |
| 2025-02-04 | CZIRR JAMES C 10% owner | Gift | −10,000 | 721,416 | ||
| 2025-02-03 | CZIRR JAMES C 10% owner | Gift | −10,000 | 731,416 | ||
| 2025-01-23 | Shlevin Harold H. Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-01-23 | Zordani Richard A. Jr. Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-01-23 | Uihlein Richard E Director | Grant or award | +32,520 | $1.23 | $40K | 10,301,271 |
| 2025-01-23 | Uihlein Richard E Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-01-23 | Schwartz Elissa J. Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-01-23 | Rubin Marc Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-01-23 | OMENN GILBERT S Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-01-23 | LEWIS JOEL President and CEO | Grant or award · Stock Option (right to buy) | +91,000 | 91,000 | ||
| 2025-01-23 | LEWIS JOEL President and CEO | Grant or award · Restricted Stock Unit | +84,000 | 84,000 | ||
| 2025-01-23 | Jamil Khurram Chief Medical Officer | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2025-01-23 | Jamil Khurram Chief Medical Officer | Grant or award · Restricted Stock Unit | +60,000 | 60,000 |
Page 12 of 15 · 291 trades